Table 1 Patient characteristics (n = 35)
Variables | |
|---|---|
Age at initial diagnosis (years), median (range) | 51 (28–77) |
FIGO stage at diagnosis (%)a | |
Early (I + II) | 13 (44.8%) |
Advanced (III + IV) | 16 (55.2%) |
Platinum resistant recurrence (%) | 12 (34.3%) |
Serum CA-125 level at recurrence (U/mL), median (range) | 35.1 (3.90–829.2) |
Serum CA-199 level at recurrence (U/mL), median (range) | 12.01 (0.5–1000) |
Number of recurrent tumor lesions | |
Single (%) | 15 (42.9%) |
Multiple (%) | 20 (57.1%) |
Type of treatment | |
Secondary cytoreduction surgery + chemotherapy | 27 (77.1%) |
Chemotherapy | 8 (22.9%) |
Follow up time (months), median (range)b | 36.5 (7–155) |
Disease status at last follow upb | |
Dead (%) | 22 (64.7%) |
Alive with disease (%) | 12 (35.3%) |
Progression-free survival (months), median (range) | 13 (2–135) |
Post-relapse survival (months), median (range) | 17 (4–126) |